How can Alzheimer's disease be detected earlier? What prevention strategies are currently available, and where is research heading? These questions will take center stage at the final symposium of the ADIS project, which will take place on June 25 and 26 at Fraunhofer SCAI in Schloss Birlinghoven.
"Towards Earlier Diagnosis of Alzheimer's Disease" is the theme of the final symposium for the ADIS research project. The event will be held on June 25 and 26, 2025, at the Fraunhofer Institute for Algorithms and Computing SCAI, located at Schloss Birlinghoven.
The symposium will present key results from the ADIS project (Early Diagnosis of Alzheimer's Disease by Immune Profiling of Cytotoxic Lymphocytes and Recording of Sleep Disturbances). In addition, international experts will discuss new approaches to the early diagnosis of neurodegenerative diseases.
The first day of the event will focus on current insights into early diagnosis. Talks from experts in biology, medicine, and computer science will provide diverse perspectives. Alongside blood biomarkers, data from digital devices that monitor behavior and sleep are becoming a focal point. These sensors are suitable for use in home environments, and analyzing the recorded data can offer early indicators of disease-specific symptoms.
On the second day, the symposium will look ahead, as experts discuss prevention strategies and upcoming research initiatives. Round-table discussions will encourage exchange on potential future collaborations.
The ADIS project: immune profiling and sleep as key factors
Over the past three years, researchers within the ADIS project have investigated cytotoxic lymphocytes in blood samples to assess their potential as biomarkers for Alzheimer's disease. They have also studied the impact of sleep disturbances on these biomarkers.
Fraunhofer SCAI coordinated the project and developed advanced artificial intelligence (AI) models to enhance understanding of the interplay between biological and immunological processes and the pathophysiological symptoms of Alzheimer's disease.
Participation in the symposium is free of charge for online attendees. For in-person attendance, a conference fee of €150 applies (€75 for attendance on a single day). The registration deadline is May 15, 2025.
For more information on the program and registration to the symposium, please visit the website:
https://adis-project.eu/final-symposium
Think only obese people get sleep apnea? Think again, says largest study yet